Rock Springs Capital Management LP Celldex Therapeutics, Inc. Transaction History
Rock Springs Capital Management LP
- $3.83 Billion
- Q1 2024
A detailed history of Rock Springs Capital Management LP transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Rock Springs Capital Management LP holds 1,372,185 shares of CLDX stock, worth $45.7 Million. This represents 1.51% of its overall portfolio holdings.
Number of Shares
1,372,185
Previous 969,646
41.51%
Holding current value
$45.7 Million
Previous $38.5 Million
49.76%
% of portfolio
1.51%
Previous 0.96%
Shares
8 transactions
Others Institutions Holding CLDX
# of Institutions
207Shares Held
61.2MCall Options Held
291KPut Options Held
246K-
Wellington Management Group LLP Boston, MA7.65MShares$255 Million0.06% of portfolio
-
Black Rock Inc. New York, NY4.51MShares$150 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.65MShares$122 Million0.0% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.12MShares$104 Million2.11% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.09MShares$103 Million0.02% of portfolio
About Celldex Therapeutics, Inc.
- Ticker CLDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,772,400
- Market Cap $1.56B
- Description
- Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...